A cannabis drug offers new hope to thousands of Britons with untreatable forms of epilepsy, a groundbreaking study has shown.
The cannabidiol compound reduced convulsive seizures by nearly 40% in teenagers and children with Dravet syndrome, a rare and severe epileptic condition that does not respond to traditional drug treatments.